NPSA updates methotrexate patient safety alert
The National Patient Safety Agency has published an update to the patient
safety alert about oral methotrexate that it issued earlier this year
(PJ, 31 July, p144).
The action follows confusion among patients and clinicians about one
aspect of the alert. The alert had included templates that set out the
core information the NPSA expects patients to receive. However, this
had resulted in a number of queries.
Therefore, the update states: “The NPSA wishes to emphasise that
the recommended core content should be regarded as only to be used in
conjunction with existing guidance and patient information from authoritative
sources. It is not intended to replace such material.” It adds
that staff should adapt the document for local preferences, style and
approach. “If health care staff are confident that the information
they currently provide to patients addresses all the areas outlined within
the patient information section of the alert, no further action is required
under [this point],” the update notes. |
The
Pharmaceutical Journal
Acrobat
Reader